Health | Science | Technology | Space | Sports | Entertainment | Mobile | Games | Economy | Politics | Movies | Music | [Top News]

NIH issues SBIR grant to Titan pharmaceutical for Parkinson’s disease treatment

July 27, 2010
Titan Pharmaceuticals, Inc.today announced that the National Institutes of Health (NIH) has awarded the company a grant under the Small Business Innovation Research (SBIR) program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke (NINDS).

4 Responses to “NIH issues SBIR grant to Titan pharmaceutical for Parkinson’s disease treatment”

  1. Yesturdays Arbeit für Morgen – ein Blick auf einige Beispiele…

    Beachtet dieses Beispiel, über gezeigt Megan hardvalder an Facebook und gefunden ihm vor um zu sein sehr informativ und auch der Punkt…

  2. Het werk van Yesturdays voor morgen – een blik op sommige voorbeelden…

    Enkel opgemerkt dit voorbeeld, via David McCormick linkedin en geloof het om te zijn zeer informatief en ook het punt…

  3. Hanna says:

    Yesturdays work for tomorrow – a look at some examples…

    Just noticed this example, via David hardvalder on Twitter and found it to be very informative and too the point…

  4. clothing says:

    Yesturdays Arbeit für Morgen – ein Blick auf einige Beispiele…

    Gerade beachtet dieses Beispiel, über gezeigt jon McCormick an linkedin und stellen Sie sich es vor um zu sein extrem informativ und auch der Punkt…

Leave a Reply


High-throughput sequencing can detect early signs of leukemia relapse

A study led by researchers at Fred Hutchinson Cancer Research Center has found that a next-generation, high-speed DNA-decoding technology called high-throughput sequencing can detect the earliest signs of potential relapse in nearly twice the number of leukemia patients as compared to flow cytometry, the current gold standard for detecting minimal ...

U.S. support for Global Fund may be ‘America’s greatest global health legacy’

"This year marks the 10th anniversary of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the world's most powerful tool in the fight against the three pandemics," Jonathan Klein, co-founder and CEO of Getty Images, Inc., writes in this post in the Huffington Post Blog.

Smartphones can improve QOL for people with poor vision

iPhones and other smartphones can be a huge help to the visually impaired, but few vision doctors are recommending them to patients, according to a study co-authored by a Loyola University Chicago Stritch School of Medicine ophthalmologist.

Treating prenatal maternal infections could improve birth outcomes, study suggests

Clinical trials are underway to test an azithromycin-based combination treatment for pregnant women, "which could tackle some of the leading preventable causes of death for babies in sub-Saharan Africa," according to researchers from the London School of Hygiene & Tropical Medicine (LSHTM), who published a report on Wednesday in the ...

Head impacts may worsen contact sport athletes’ ability to acquire new information

A new study suggests that head impacts experienced during contact sports such as football and hockey may worsen some college athletes' ability to acquire new information. The research is published in the May 16, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

Immediate response required to curb spread of artemisinin-resistant malaria in Burma

In this Wall Street Journal opinion piece, Jay Winsten, associate dean at the Harvard School of Public Health, and Trish Stroman, a principal at the Boston Consulting Group, examine "the emergence in Southeast Asia of malarial parasites resistant to artemisinin -- the current gold-standard drug for treating the disease," writing ...

DSM needs radical change from its current ‘field guide’ form

The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of ...